erbb2 gene amplification
Showing 1 - 4 of 4
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Endometrial Adenocarcinoma, ERBB2 Gene Amplification, Recurrent Uterine Corpus Carcinoma Trial in Philadelphia (Laboratory
Completed
- Endometrial Adenocarcinoma
- +4 more
- Laboratory Biomarker Analysis
- Trastuzumab
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 30, 2019
Stomach Tumors, Tumors Metastasis, ERBB2 Gene Amplification Trial in Guangzhou (Trastuzumab, Docetaxel, Capecitabine)
Completed
- Stomach Neoplasms
- +2 more
- Trastuzumab
- +2 more
-
Guangzhou, Guangdong, ChinaMedical Oncology,Sun Yat-sen University Cancer Center
Nov 17, 2016